SCHEMBL5562091

SCHEMBL5562091

COc1ccc(-c2cc(Nc3ncnc4cc(OCC5CCN(C)CC5)c(OC)cc34)n[nH]2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 3/20 0.65
▸ SRC P12931 2/20 0.65
▸ EGFR P00533 19/20 0.65
▸ FGFR1 P11362 2/20 0.59
▸ FLT1 P17948 2/20 0.59
▸ FLT4 P35916 2/20 0.59
▸ BMPR1B O00238 1/20 0.59
▸ PLK4 O00444 1/20 0.59
▸ CIT O14578 1/20 0.59
▸ GAK O14976 1/20 0.59
▸ EPHB6 O15197 1/20 0.59
▸ RIPK2 O43353 1/20 0.59
▸ ROCK2 O75116 1/20 0.59
▸ STK10 O94804 1/20 0.59
▸ MAP4K4 O95819 1/20 0.59
▸ ABL1 P00519 1/20 0.59
▸ ERBB2 P04626 1/20 0.59
▸ LCK P06239 1/20 0.59
▸ FYN P06241 1/20 0.59
▸ CSF1R P07333 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5566572 0.99 KDR (0.64) KDRSRCEGFRFGFR1FLT1
SCHEMBL5565975 0.94 EGFR (0.68) KDRSRCEGFRFGFR1FLT1
SCHEMBL5567635 0.93 EGFR (0.68) KDRSRCEGFRFGFR1FLT1
SCHEMBL5567690 0.93 EGFR (0.73) KDREGFR
Hydrochloric Acid SCHEMBL6444589 0.92 EGFR (0.72) KDREGFRFGFR1FLT1FLT4
SCHEMBL5566880 0.90 KDR (0.65) KDRSRCEGFRFGFR1FLT1
SCHEMBL5566528 0.86 EGFR (0.61) KDRSRCEGFRFGFR1FLT1
SCHEMBL5562072 0.84 SRC (0.55) KDRSRCEGFRKIT
SCHEMBL5566455 0.83 EGFR (0.53) KDRSRCEGFRKIT
SCHEMBL28583570 0.79 KDR (0.87) KDRSRCEGFRFGFR1FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262201-B1 For the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals ASTRAZENECA AB (SE) 2007-08-28 — — US disclosed
Send feedback